Lateral opening site of human oligopeptide transporter 2 plays a key role in the interaction with polymyxins
Multidrug-resistant (MDR) Gram-negative bacteria pose a critical global health threat, while polymyxins remain a last-line therapy. However, their clinical use is limited by nephrotoxicity.